Fourth, although we regarded plasma EBV DNA as an extremely significant complement to the clinical staging system, use of this measure in combination with other important biomarkers (i.e. circulating fibrinogen 20 ) could help provide more precise treatment choices.
← all excerpts
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area.
1
—
—